Literature DB >> 2199419

Estimation of complications for linear accelerator radiosurgery with the integrated logistic formula.

J C Flickinger1, M C Schell, D A Larson.   

Abstract

Radiosurgery techniques permit high doses of single fraction irradiation to be administered to small volumes of tumor with relative sparing of surrounding brain tissue. The tolerance of surrounding normal brain tissue to dose distributions from linear accelerator radiosurgery with different collimator sizes is an important factor that must be estimated by anyone using these treatment techniques. The exponential and linear quadratic versions of the integrated logistic formula were used to estimate the probability of brain necrosis at different doses for radiosurgical dose distributions administered by a 6 MV linear accelerator with a 5 arc technique for collimator sizes from 12.5 to 30 mm in diameter. Dose-volume isoeffect curves for a 3% risk of brain necrosis from linear accelerator radiosurgery were then calculated. These curves approximate those calculated for gamma knife radiosurgery and a published 1% dose-volume isoeffect line predicted for proton beam irradiation. Similar dose-volume isoeffect curves were calculated for single fraction radiosurgery boosts administered after 30 Gy of whole brain irradiation in 12 fractions. The integrated logistic formula appears to be a useful tool for estimating tolerance and providing guidelines for prescribing radiation doses for linear accelerator radiosurgery.

Entities:  

Mesh:

Year:  1990        PMID: 2199419     DOI: 10.1016/0360-3016(90)90146-b

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

1.  Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases.

Authors:  Kazuhiro Ohtakara; Shinya Hayashi; Noriyuki Nakayama; Naoyuki Ohe; Hirohito Yano; Toru Iwama; Hiroaki Hoshi
Journal:  J Neurooncol       Date:  2012-03-06       Impact factor: 4.130

Review 2.  Radiosurgery in the treatment of brain metastases: critical review regarding complications.

Authors:  Marcos Vinícius Calfat Maldaun; Paulo Henrique Pires Aguiar; Frederick Lang; Dima Suki; David Wildrick; Raymond Sawaya
Journal:  Neurosurg Rev       Date:  2007-10-24       Impact factor: 3.042

Review 3.  External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma.

Authors:  Neil K Taunk; Fabio Y Moraes; Freddy E Escorcia; Lucas Castro Mendez; Kathryn Beal; Gustavo N Marta
Journal:  Expert Rev Anticancer Ther       Date:  2016-02-09       Impact factor: 4.512

Review 4.  Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.

Authors:  Martin Kocher; Andrea Wittig; Marc Dieter Piroth; Harald Treuer; Heinrich Seegenschmiedt; Maximilian Ruge; Anca-Ligia Grosu; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2014-04-09       Impact factor: 3.621

5.  A technique for stereotactic radiosurgery treatment planning with helical tomotherapy.

Authors:  Emilie T Soisson; Peter W Hoban; Thomas Kammeyer; Jeffrey M Kapatoes; David C Westerly; Amar Basavatia; Wolfgang A Tomé
Journal:  Med Dosim       Date:  2011       Impact factor: 1.482

Review 6.  [Stereotactic one-time irradiation (radiosurgery). The methods, indications and results].

Authors:  J Debus; A Pirzkall; W Schlegel; M Wannenmacher
Journal:  Strahlenther Onkol       Date:  1999-02       Impact factor: 3.621

7.  Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease.

Authors:  Stefano Telera; Alessandra Fabi; Andrea Pace; Antonello Vidiri; Vincenzo Anelli; Carmine Maria Carapella; Laura Marucci; Francesco Crispo; Isabella Sperduti; Alfredo Pompili
Journal:  J Neurooncol       Date:  2013-03-25       Impact factor: 4.130

8.  The possible role of linac-based stereotactic radiotherapy in the treatment of multifocally and heterochronously recurrent malignant astrocytomas. A case report.

Authors:  M Nagane; S Shibui; H Oyama; K Nomura; M Sumi; K Tokuuye; Y Akine
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

9.  Retrospective analysis of linac-based radiosurgery for arteriovenous malformations and testing of the Flickinger formula in predicting radiation injury.

Authors:  I A Cetin; R Ates; J Dhaens; G Storme
Journal:  Strahlenther Onkol       Date:  2012-11-07       Impact factor: 3.621

Review 10.  Radiotherapeutic alternatives for previously irradiated recurrent gliomas.

Authors:  Stephanie E Combs; Jürgen Debus; Daniela Schulz-Ertner
Journal:  BMC Cancer       Date:  2007-08-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.